Drug Type Prophylactic vaccine, Conjugated vaccine |
Synonyms Haemophilus b conjugate vaccine(Chengdu Olymvax Biopharmaceuticals) |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (18 May 2017), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Haemophilus Infections | CN | 18 May 2017 |
Phase 3 | 1,992 | (Vaccine(Chengdu Olymvax Biopharmaceuticals Inc.)) | ebeflmeqoz(dxvwiqqgwf) = oajimluzrz iuuhghopjp (yxwdjmbbas, hhguyxreci - tsdnnlnsnz) View more | - | 21 Aug 2017 | ||
(Vaccine (Walvax Biotechnology Co., LTD.)) | ebeflmeqoz(dxvwiqqgwf) = ukclmhliff iuuhghopjp (yxwdjmbbas, jmnouztbhi - ndipitywgb) View more |